Anti-tumor effector and mitochondrial function during cytotoxic T cell migration in metabolically challenging microenvironments

被引：0
|
作者：
Dieteren, C. E. J. [1 ,2 ]
Wagena, E. [1 ]
Weigelin, B. [1 ,3 ]
Scorrano, L. [4 ,5 ]
Manjeri, G. R. [2 ]
Willems, P. H. G. M. [2 ]
Koopman, W. J. H. [2 ]
Friedl, P. [1 ,3 ]
机构：
[1] Radboud Univ Nijmegen, Med Ctr, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Biochem, NL-6525 ED Nijmegen, Netherlands
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Univ Padua, Dept Biol, Padua, Italy
[5] Venetian Inst Mol Med, Padua, Italy
来源：
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2016年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5.27
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [41] Identification of PP2A as an intrinsic checkpoint of T-bet and anti-tumor effector function of NK cells
    Yamamae, Yui
    Kawada, Manabu
    Hayakawa, Yoshihiro
    CANCER SCIENCE, 2023, 114 : 814 - 814
  • [42] Cytotoxic T-lymphocytes and the recognition of tumor antigens. An approach to anti-tumor vaccines?
    Peiper, M
    Goedegebuure, PS
    Eberlein, TJ
    Zornig, C
    ZENTRALBLATT FUR CHIRURGIE, 1997, 122 (03): : 141 - 148
  • [43] CD4+T cell help differentially influences anti-tumor immunity as a function of T cell avidity
    Zhu, Ziqiang
    Singh, Vinod
    Bronte, Vincenzo
    Feigenbaum, Lionel
    Hurwitz, Arthur
    CANCER RESEARCH, 2011, 71
  • [44] Function of T follicular helper cells in anti-tumor immunity
    Nurieva, Roza I.
    Liu, Zhongshan
    Gangadharan, Achintyan
    Bieerkehazhi, Shayahati
    Zhao, Yang-Zhi
    Alekseev, Andrei
    Sahoo, Anupama
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [45] Identification of PP2A as an intrinsic checkpoint of T-bet and anti-tumor effector function of NK cells
    Yamamae, Yui
    Kawada, Manabu
    Hayakawa, Yoshihiro
    CANCER SCIENCE, 2023, 114 : 1165 - 1165
  • [46] BIOLOGICAL RESPONSE MODIFIER AS ANTIGEN - OK432-SPECIFIC T-CELL CLONE AS AN ANTI-TUMOR EFFECTOR CELL
    OZAKI, S
    SUGINOSHITA, T
    CELLULAR IMMUNOLOGY, 1989, 120 (02) : 477 - 481
  • [47] Adrenergic signaling augments cytotoxic T-cell anti-tumor function in p53-deficient head and neck cancer.
    Silverman, Deborah
    Leahey, Sara
    Akhter, Shamima
    Xie, Tongxin
    Wang, Yunfei
    Doordjuin, Elien
    Calin, George
    Myers, Jeffrey
    Hwu, Patrick
    CANCER RESEARCH, 2021, 81 (13)
  • [48] Ginsenoside Rg1 improves anti-tumor efficacy of adoptive cell therapy by enhancing T cell effector functions
    Liu, Yue
    An, Lingna
    Yang, Chengfei
    Wang, Xiaoqi
    Huang, Ruihao
    Zhang, Xi
    BLOOD SCIENCE, 2023, 5 (03): : 170 - 179
  • [49] PP2A negatively regulates anti-tumor effector function of NK cells
    Yamamae, Yui
    Hara, Daisuke
    Kawada, Manabu
    Hayakawa, Yoshihiro
    CANCER SCIENCE, 2024, 115 : 576 - 576
  • [50] Hypoxia regulates the differentiation and anti-tumor effector functions of γδT cells in oral cancer
    Sureshbabu, S. K.
    Chaukar, D.
    Chiplunkar, S. V.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2020, 201 (01): : 40 - 57
12345